The role of sphingolipids in cardiovascular pathologies

Biomedit︠s︡inskai︠a︡ khimii︠a︡
A V AlessenkoI N Kurochkin


Cardiovascular diseases (CVD) remain the leading cause of death in industrialized countries. One of the most significant risk factors for atherosclerosis is hypercholesterolemia. Its diagnostics is based on routine lipid profile analysis, including the determination of total cholesterol, low and high density lipoprotein cholesterol, and triglycerides. However in recent years, much attention has been paid to the crosstalk between the metabolic pathways of the cholesterol and sphingolipids biosynthesis. Sphingolipids are a group of lipids, containing a molecule of aliphatic alcohol sphingosine. These include sphingomyelins, cerebrosides, gangliosides and ceramides, sphingosines, and sphingosine-1-phosphate (S-1-P). It has been found that catabolism of sphingolipids is associated with catabolism of cholesterol. However, the exact mechanism of this interaction is still unknown. Particular attention as CVD inducer attracts ceramide (Cer). Lipoprotein aggregates isolated from atherosclerotic pluques are enriched with Cer. The level of Cer and sphingosine increases after ischemia reperfusion of the heart, in the infarction zone and in the blood, and also in hypertension. S-1-P exhibits pronounced cardioprotective properties. Its conte...Continue Reading


Dec 2, 1993·Biochimica Et Biophysica Acta·A S HärmäläJ P Slotte
Apr 1, 1996·Clinical Immunology and Immunopathology·L J FanningG E Wu
May 8, 1998·Journal of Pharmaceutical and Biomedical Analysis·G A CordisD K Das
Jun 26, 1998·Clinica Chimica Acta; International Journal of Clinical Chemistry·K W WodzigW T Hermens
Feb 25, 2000·Biologicals : Journal of the International Association of Biological Standardization·K Muller-Breitkreutz, T Evers
Feb 15, 2001·Journal of Pediatric Surgery·W ChengP K Tam
Apr 12, 2001·International Journal of Experimental Pathology·B GuertlG Hoefler
Oct 2, 2001·The Journal of Biological Chemistry·A R LeventhalI Tabas
Jun 12, 2002·Journal of Molecular and Cellular Cardiology·Sandrine LecourMichael N Sack
Jul 10, 2003·American Heart Journal·Douglas H DeutschmanRoger A Sabbadini
Aug 29, 2003·Biochemical and Biophysical Research Communications·Yu FukudaYasuyuki Igarashi
Apr 28, 2004·Journal of the American College of Surgeons·Jianhua CuiDipak K Das
May 15, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Malgorzata Czarny, Jan E Schnitzer
Sep 29, 2004·Circulation·Zhu-Qiu JinJoel S Karliner
Sep 16, 2005·Journal of Lipid Research·Papasani V SubbaiahKewei Wang
Jul 29, 2006·The Biochemical Journal·Philipp RovinaFrédéric Bornancin
Feb 7, 2007·Current Opinion in Pharmacology·Stephan L M Peters, Astrid E Alewijnse
Feb 13, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Christopher K MeansJoan Heller Brown
Mar 16, 2007·European Journal of Clinical Investigation·M TölleM van der Giet
Aug 19, 2007·Journal of Lipid Research·Kelley M Argraves, W Scott Argraves
Oct 12, 2007·Biochimica Et Biophysica Acta·Susheel Gundewar, David J Lefer
Nov 1, 2007·Acta Physiologica·M BaranowskiJ Gorski
Jan 25, 2008·Nature Reviews. Molecular Cell Biology·Yusuf A Hannun, Lina M Obeid
Apr 18, 2008·Journal of Biochemical and Molecular Toxicology·Donald A VesseyJoel S Karliner
May 24, 2008·Journal of Lipid Research·Sarah T PruettAlfred H Merrill
Aug 30, 2008·Sub-cellular Biochemistry·Andreas Billich, Thomas Baumruker
Oct 23, 2008·Lancet·Yuri A Zarate, Robert J Hopkin
Feb 24, 2009·Cardiovascular Research·Junsuke Igarashi, Thomas Michel
Feb 24, 2009·Cardiovascular Research·Katherine Sattler, Bodo Levkau
Mar 14, 2009·Cardiovascular Research·Christopher K Means, Joan Heller Brown
Mar 17, 2010·Prostaglandins & Other Lipid Mediators·Paweł KnappJan Górski
Apr 7, 2010·Progress in Lipid Research·Sonia GulatiStephen L Sturley

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.